Name
Merus N.V.
Company Description
At Merus, we are clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer. Utilizing our proprietary technology platforms, we are developing innovative multispecific antibody therapeutics, referred to as Multiclonics®.
Website
Featured Exhibitor
Yes
Product Categories (7)
Biomarkers, Molecular Diagnostics, Tumor Biology
Phone (If provided, phone will display online and in-print)
617-401-4499
Address
Cambridge, MA
United States
United States
Recognition
Products
Relevance
